CytoSorbents Reports First Quarter 2024 Results
May 09, 2024 16:17 ET
|
CytoSorbents
CytoSorbents Reports First Quarter 2024 Results
Psoriasis Vulgaris Clinical Trial Pipeline Analysis Demonstrates 50+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight
May 09, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, May 09, 2024 (GLOBE NEWSWIRE) -- Psoriasis Vulgaris Clinical Trial Pipeline Analysis Demonstrates 50+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm,...
Contribuer à sauver des vies : 2 300 enseignants ont reçu la formation sur les interventions en cas de surdose d'opioïdes pour enseigner aux élèves du secondaire comment réagir face à une surdose soupçonnée d'opioïdes
May 09, 2024 09:31 ET
|
La Fondation ACT
OTTAWA, 09 mai 2024 (GLOBE NEWSWIRE) -- La Fondation Advanced Coronary Treatment (ACT) a annoncé aujourd'hui qu'elle a terminé la phase 1 de sa formation en réponse aux surdoses d'opioïdes (OORT)....
Helping save lives: 2,300 teachers received the Opioid Overdose Response Training to teach high school students how to react when facing a suspected opioid overdose
May 09, 2024 09:31 ET
|
ACT Foundation of Canada
OTTAWA, May 09, 2024 (GLOBE NEWSWIRE) -- The Advanced Coronary Treatment (ACT) Foundation announced today it has completed Phase 1 of its Opioid Overdose Response Training (OORT). As a result, 2,300...
Monopar Therapeutics Reports First Quarter 2024 Financial Results and Strategic Focus on its Radiopharma Pipeline
May 09, 2024 07:00 ET
|
Monopar Therapeutics Inc.
Initiated MNPR-101-Zr First-in-Human Phase 1 Radiopharma Clinical Trial MNPR-101-RIT Phase 1 Clinical Trial Targeted for Launch as Early as Q4 2024 or Q1 2025 WILMETTE, Ill., May 09, 2024 (GLOBE...
Annual NMDP Gala in New York Raises More Than $560,000, Enabling More Patients to Receive Life-Saving Cell Therapy
May 08, 2024 14:46 ET
|
NMDP
The annual NMDP Gala in New York raises critical funds, enabling more patients to receive life-saving cell therapy.
3. kvartal 2023/24 - Første salg af XM30 er gennemført
May 08, 2024 12:20 ET
|
Chemometec A/S
MEDDELELSE NR. 262 Periodemeddelelse for 3. kvartal 2023/24 (1. januar - 31. marts 2024) Første salg af XM30 er gennemført Omsætningen faldt i 3. kvartal med 6% til DKK 98,9...
Q3 2023/24 - First sale of the XM30 completed
May 08, 2024 12:20 ET
|
Chemometec A/S
ANNOUNCEMENT NO. 262 Trading statement for Q3 2023/24 (1 January - 31 March 2024) First sale of the XM30 completed Revenue declined by 6% in the third quarter of 2023/24 to DKK 98.9...
Biopharmaceuticals Packaging Market Size Expected to Reach USD 42.08 Bn by 2032
May 08, 2024 11:32 ET
|
Precedence Research
Ottawa, May 08, 2024 (GLOBE NEWSWIRE) -- The global biopharmaceuticals packaging market size was valued at USD 19.37 billion in 2023 and is predicted to hit around USD 38.46 billion by 2031, a study...
Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Billion in 2024
May 08, 2024 08:30 ET
|
FN Media Group LLC
PALM BEACH, Fla., May 08, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - There is much activity in finding better ways in mitigating muscle loss for the cancer patients… many clinical...